NB-1008

inactivated nasal influenza vaccine · NanoBio Corporation

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for NB-1008, covering 2011-04-12 to 2011-04-12. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Immunogenicity Study of Inactivated Nasal Influenza Vaccine NB-1008 [Phase 1]